Neurovascular Complications of Ovarian Hyperstimulation Syndrome (OHSS): From Pathophysiology to Recent Treatment Options

被引:9
作者
Calabro, Rocco S. [1 ]
Gervasi, Giuseppe [2 ]
Leo, Antonino [1 ]
De Luca, Rosaria [1 ]
Balletta, Tina [1 ]
Casella, Carmela [2 ]
Triolo, Onofrio [3 ]
Bramanti, Placido [1 ]
机构
[1] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy
[2] Univ Messina, Dept Neurosci, Messina, Italy
[3] Univ Messina, Dept Obstet Gynecol & Reprod Med, Messina, Italy
关键词
Arterial ischemia assisted reproductive technology; follicle stimulation hormone; iatrogenic complications; mortality risk; neurovascular complications; ovarian hyperstimulation syndrome;
D O I
10.2174/1872214808666140606142820
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ovarian hyperstimulation syndrome (OHSS) is a severe iatrogenic complication of ovulation induction, which has a very serious impact on the patient's health, as it is often associated with a high morbidity and mortality risk. Indeed, patients classified as having severe OHSS presented with liquid imbalance signs (such as rapid weight gain, tense ascites, respiratory difficulty and progressive oliguria), which are related to the fluid shift from the intravascular space to third space compartments subsequent to an increased capillary permeability. In this way, cardiovascular system findings include decreased intravascular volume, decreased blood pressure, decreased central venous perfusion, and compensatory increased heart rate and cardiac output with arterial vasodilation might be found concomitantly. Notwithstanding that venous thromboembolic phenomena are a possible complication in advanced phases of OHSS, arterial ischemia involving the cerebral circulation is a rare but recently reported problem. The pathogenesis of thromboembolism in OHSS is not fully understood, even though hemoconcentration and blood hyperviscosity seem to play a role in developing thrombotic changes into both venous and arterial system. Interestingly, the presence of cardiac abnormalities in combination with inherited or acquired hypercoagulable state seems to increase the risk of cerebral infarct in these subjects, as recently shown by our group. This review is aimed at investigating the pathomechanism and the management of neurovascular complications related to OHSS, including new treatment options.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 53 条
[1]   Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures [J].
Aboulghar, MA ;
Mansour, RT .
HUMAN REPRODUCTION UPDATE, 2003, 9 (03) :275-289
[2]   An 'epidemic' of severe OHSS: a price we have to pay? [J].
Abramov, Y ;
Elchalal, U ;
Schenker, JG .
HUMAN REPRODUCTION, 1999, 14 (09) :2181-2183
[3]   Guidelines for the early management of adults with ischemic stroke - A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups [J].
Adams, Harold P., Jr. ;
del Zoppo, Gregory ;
Alberts, Mark J. ;
Bhatt, Deepak L. ;
Brass, Lawrence ;
Furlan, Anthony ;
Grubb, Robert L. ;
Higashida, Randall T. ;
Jauch, Edward C. ;
Kidwell, Chelsea ;
Lyden, Patrick D. ;
Morgenstern, Lewis B. ;
Qureshi, Adnan I. ;
Rosenwasser, Robert H. ;
Scott, Phillip A. ;
Wijdicks, Eelco F. M. .
STROKE, 2007, 38 (05) :1655-1711
[4]  
Ahmed S. U., 2009, Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof, Patent No. [CA2713943, 2713943]
[5]   Gonadotrophin-releasing hormone antagonists for assisted conception: A Cochrane Review [J].
Al-Inany, H. G. ;
Abou-Setta, A. M. ;
Aboulghar, M. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2007, 14 (05) :640-649
[6]  
Alper Michael M, 2009, J Exp Clin Assist Reprod, V6, P3
[7]  
Arce S. J. C., 2012, Composition for controlled ovarian stimulation, Patent No. [WO2012042381, AU12293647, 12293647]
[8]  
Arce S. J. C., 2012, Composition for controlled ovarian stimulation, Patent No. [WO2012042381, AU12293647, 2012042381]
[9]   SEVERE OVARIAN HYPERSTIMULATION SYNDROME IN ASSISTED REPRODUCTIVE TECHNOLOGY - DEFINITION OF HIGH-RISK GROUPS [J].
ASCH, RH ;
LI, HP ;
BALMACEDA, JP ;
WECKSTEIN, LN ;
STONE, SC .
HUMAN REPRODUCTION, 1991, 6 (10) :1395-1399
[10]   Dual renin-angiotensin blockage and total embryo cryopreservation is not a risk-free strategy in patients at high risk for ovarian hyperstimulation syndrome [J].
Ata, Baris ;
Yakin, Kayhan ;
Alatas, Cengiz ;
Urman, Bulent .
FERTILITY AND STERILITY, 2008, 90 (03) :531-536